FDA Orange Book — Drug Patent & Exclusivity API
Pricing
from $100.00 / 1,000 drug patent records
FDA Orange Book — Drug Patent & Exclusivity API
Track FDA Orange Book drug patents and exclusivity data. Clean JSON for IP counsel, brand teams and AI agents.
Pricing
from $100.00 / 1,000 drug patent records
Rating
0.0
(0)
Developer
NexGenData
Maintained by CommunityActor stats
0
Bookmarked
7
Total users
3
Monthly active users
2 days ago
Last modified
Categories
Share
FDA Orange Book
Track FDA Orange Book drug patents and exclusivity data. Built for IP counsel, brand teams, researchers and AI agents.
Factual public data — not financial or investment advice.
⏰ Run this as a patent-cliff watch (recommended)
Every IP registry actor is a monitoring subscription, not a one-shot lookup. Schedule a weekly sweep and catch new filings as they land:
{"query": "drug name","limit": 100}
Weekly cron (0 8 * * 1) turns this into an always-on patent-cliff watch.
📊 What you get
Clean JSON, one record per record (full output has 25 fields):
applicant— ApplicantapplicantFullName— Applicant Full NameapplicationNumber— Application NumberapplicationType— Application TypeapplicationTypeLabel— Application Type LabelapprovalDate— Approval DateapprovalDateText— Approval Date TextdosageFormRoute— Dosage Form RouteearliestProtectionExpiry— Earliest Protection ExpiryestimatedGenericEntryDate— Estimated Generic Entry Date
Pricing: $0.10 per record (Pay-Per-Event) — about 10 records per $1.
🤖 Use with AI agents
Point Claude, the OpenAI Agents SDK, an n8n flow or any MCP-aware client at it and run FDA Orange Book drug patents and exclusivity on demand.
Sample agent prompt:
List Orange Book patents expiring for a drug and its exclusivity dates.
Agentic payments (x402): Supports agentic payment via x402 — agents can call this actor with USDC, no API key required.
🔗 Related IP actors
Prior-art & patent web: USPTO Patent Search, USPTO Patent Grants, USPTO Grants Tracker, WIPO PatentScope, PatentsView Inventors
IP agent front door: Patents & Trademarks IP MCP
Data from public intellectual-property registries. Factual public data — not financial or investment advice.